Status:
UNKNOWN
VALIDATION OF THE VIBe INTRAOPERATIVE BLEEDING SCALE IN LIVER SURGERY
Lead Sponsor:
Hospital Miguel Servet
Collaborating Sponsors:
Spanish Association of Surgeons (AEC)
Conditions:
Surgical Hemorrhage
Liver Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Surgical hemostasis has become one of the fundamental principles for the advancement of surgery. The use of hemostatic agents is standard in many surgical specialties, although the lack of consensus o...
Detailed Description
Surgical hemostasis has become one of the fundamental principles for the advancement of surgery. The use of hemostatic agents is standard in many surgical specialties, with greater use in major surger...
Eligibility Criteria
Inclusion
- Patients age ≥ 18, scheduled for liver surgery, by open or minimally invasive approach, regardless of diagnosis;
- ASA score \<4
- They have signed the informed consent.
Exclusion
- Patients with contraindications for liver surgery
- Emergency surgical interventions
- Patients \<18 years
- Patients who have not signed the informed consent.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2023
Estimated Enrollment :
259 Patients enrolled
Trial Details
Trial ID
NCT05369988
Start Date
July 1 2022
End Date
April 1 2023
Last Update
May 11 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mario Serradilla Martin
Zaragoza, Spain, 50008
2
Daniel Aparicio Lopez
Zaragoza, Spain, 50012